Generic name: levetiracetam
Dosage form: injection, solution, concentrate
Drug class:Pyrrolidine anticonvulsants
Medically reviewed by Drugs.com. Last updated on Oct 1, 2020.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Keppra Injection
Partial-Onset Seizures
KEPPRA is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy
KEPPRA is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy.
Primary Generalized Tonic-Clonic Seizures
KEPPRA is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Limitations of Use
Keppra Injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible.
